Diary - News
All news NH TherAguix
NH TherAguix, new Lyonbiopole's company member, is a clinical stage pharmaceutical company developing innovative nanomedicine that improve radiation therapy benefits without modifying current clinical workflows. Our leading product, AGuIX®, is a nanoparticle designed to improve the localization of solid tumors and the outcomes of radiation therapy by a unique intravenous injection.
